Policy Updates

Research in Review

NCCN Responds to Study Findings on Financial Conflicts of Interest

11/04/2016

JCP Editors

The National Comprehensive Cancer Network (NCCN) agreed that ongoing monitoring and research regarding financial conflicts of interest (COIs) at the interface of academia, medicine, and industry is critical,...

The...

11/04/2016

Journal of Clinical Pathways

Research in Review

Study Identifies Financial Ties Among NCCN Guideline Authors and Drug Industry

09/02/2016

JCP Editors

A new study that quantifies industry financial conflicts of interest (FCOIs) found that nearly nine out of 10 physicians and researchers who helped develop the National Comprehensive Network (NCCN) guidelines—work...

A new...

09/02/2016

Journal of Clinical Pathways

Research in Review

Novel ESC Position Paper Addresses Cardiotoxicity of Cancer Therapies

09/02/2016

JCP Editors

Advances in cancer treatment have improved the survival of patients, but have also increased morbidity and mortality due to treatment side effects. The effects of cancer treatments on the cardiovascular system are...

...

09/02/2016

Journal of Clinical Pathways

Research in Review

Process for Reimbursing Off-Label Cancer Drug Use Questioned

09/01/2016

JCP Editors

Off-label drug use, which is widely practiced in oncology care, accounted for $5 billion in cancer drug costs in 2010. Now a team of researchers is recommending an overhaul of the process that determines which cancer...

...

09/01/2016

Journal of Clinical Pathways

New NCCN Guidelines Advise More Physician-led Discussions of Sexual Dysfunction

04/07/2016

JCP Editors

Clinicians should take a more active role in discussing sexual dysfunction with their patients, according to updates to National Comprehensive Cancer Network (NCCN) guidelines, which were presented at the NCCN annual...

...

04/07/2016

Journal of Clinical Pathways

Major Changes to NCCN Guidelines for Multiple Myeloma Announced

04/05/2016

JCP Editors

The National Comprehensive Cancer Network (NCCN) has announced three major changes to its guidelines for the treatment of multiple myeloma (MM) that broaden the population of patients eligible to start therapy,...

The...

04/05/2016

Journal of Clinical Pathways

ASCO Endorses EAU Guidelines for Muscle-Invasive, Metastatic Bladder Cancer

03/24/2016

JCP Editors

The American Society of Clinical Oncology (ASCO) has endorsed guidelines established by the European Association of Urology (EAU) for the treatment of muscle-invasive bladder cancer (MIBC) and metastatic bladder...

The...

03/24/2016

Journal of Clinical Pathways

Research in Review

ACCC Survey Reveals New Trends in Cancer Care

09/24/2015

Since 2009, the Associated of Community of Cancer Centers (ACCC) and Lilly Oncology have conducted an annual survey to gauge the climate of oncology care in the United States. As 2015 draws to a close, the...

Since...

09/24/2015

Journal of Clinical Pathways